Inebilizumab Calms Flares in IgG4-RD With Pancreas or Hepatobiliary Involvement
(MedPage Today) — Inebilizumab (Uplizna) treatment significantly reduced the risk of flares in patients who had IgG4-related disease (IgG4-RD) with involvement in the pancreas, bile ducts, or liver, according to a post-hoc analysis of the MITIGATE…
